Last edition
News about Global Pharma
Matchpoint, Novartis Partner to Develop Oral Inhibitors for Multiple Inflammatory Diseases
Matchpoint Therapeutics has entered into an exclusive option and license agreement with Novartis to develop and commercialise oral covalent inhibitors for multiple inflammatory diseases.
Global Pharma | 28/07/2025 | By Dineshwori | 206
India's Pharma Exports Surge 92 Percent in Six Years: Anupriya Patel
Driven by various government schemes, India’s drug and pharmaceutical exports have risen from INR 1,28,028 crore in FY2018-19 to INR 2,45,962 crore in FY2024-25.
Global Pharma | 26/07/2025 | By Dineshwori | 363
India-UK FTA: A New Era for India's Pharma Industry
India currently exports pharmaceutical goods worth approximately USD 914 million (around INR 7,600 crore) annually to the UK. With the new FTA in place, this figure is expected to surge significantly, particularly for generic medicines, bulk drugs, and biosimilars.
Global Pharma | 26/07/2025 | By Darshana | 266
Laurus Labs Posts Strong Q1 FY26 Results With 31 Percent Revenue Growth
Laurus Labs has reported strong financial results for the first quarter of FY26, with consolidated revenues reaching INR 1,570 crore—a 31 percent year-on-year increase.
Global Pharma | 26/07/2025 | By Dineshwori | 1465
Mankind Pharma Expands into Sri Lanka With New Subsidiary
Mankind Pharma has incorporated a wholly owned subsidiary, Mankind Pharma Lanka (Private) Ltd., in Sri Lanka as part of its international expansion strategy.
Global Pharma | 26/07/2025 | By Dineshwori | 358
Lilly Completes Acquisition of Verve Therapeutics
Eli Lilly and Company has completed its acquisition of Verve Therapeutics, a Boston-based clinical-stage firm developing genetic medicines for cardiovascular disease.
Global Pharma | 26/07/2025 | By Mrinmoy Dey | 472
Novo Nordisk Expects EC Approval of Alhemo Label Update for Haemophilia in 2 Months
Novo Nordisk has received a positive opinion from EMA’s Committee for Medicinal Products for Human Use (CHMP) for expanded Alhemo use in haemophilia without inhibitors.
Global Pharma | 26/07/2025 | By Dineshwori | 475
PM Modi said that the India-UK Comprehensive Economic Trade Agreement (CETA) would particularly benefit India’s youth, farmers, fishermen, and the MSME sector.
Global Pharma | 25/07/2025 | By Dineshwori | 142
Klotho Neurosciences to Broaden Development Programs Beyond Neurology
Klotho Neurosciences, Inc. has announced plans to expand beyond neurology by exploring acquisitions of complementary technologies that support brain health, organ function, and longevity, building on its proprietary anti-ageing Klotho platform.
Global Pharma | 25/07/2025 | By Mrinmoy Dey | 203
The next phase of clinical development will span the U.S. and global trial sites, with a priority focus on launching Phase 3 trials for NSCLC and other solid tumors, beginning with patient enrollment in the U.S.
Global Pharma | 25/07/2025 | By Darshana | 461
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy